<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.ajmc.com/view/proposed-medicare-rate-cuts-draw-aasm-opposition-ahead-of-final-rule</loc><lastmod>2026-09-30T21:09:13.748Z</lastmod><news:news><news:publication_date>2026-09-30T21:09:13.748Z</news:publication_date>
        <news:title><![CDATA[Proposed Medicare Rate Cuts Draw AASM Opposition Ahead of Final Rule]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/sarcoma-to-heart-case-highlights-need-for-multidisciplinary-care</loc><lastmod>2026-09-30T21:00:13.100Z</lastmod><news:news><news:publication_date>2026-09-30T21:00:13.100Z</news:publication_date>
        <news:title><![CDATA[Sarcoma-to-Heart Case Highlights Need for Multidisciplinary Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/sleep-disordered-breathing-linked-to-masld-but-evidence-certainty-is-low</loc><lastmod>2026-09-30T20:13:13.036Z</lastmod><news:news><news:publication_date>2026-09-30T20:13:13.036Z</news:publication_date>
        <news:title><![CDATA[Sleep-Disordered Breathing Linked to MASLD, but Evidence Certainty Is Low]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-accepts-inhaled-treprostinil-snda-for-ipf-4-faqs-for-payers</loc><lastmod>2026-09-30T20:09:09.310Z</lastmod><news:news><news:publication_date>2026-09-30T20:09:09.310Z</news:publication_date>
        <news:title><![CDATA[FDA Accepts Inhaled Treprostinil sNDA for IPF: 4 FAQs for Payers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/what-actuarial-modeling-reveals-about-value-based-care-in-oncology</loc><lastmod>2026-09-30T19:30:58.866Z</lastmod><news:news><news:publication_date>2026-09-30T19:30:58.866Z</news:publication_date>
        <news:title><![CDATA[What Actuarial Modeling Reveals About Value-Based Care in Oncology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/payers-and-providers-map-the-path-to-community-car-t-access</loc><lastmod>2026-09-30T19:09:50.593Z</lastmod><news:news><news:publication_date>2026-09-30T19:09:50.593Z</news:publication_date>
        <news:title><![CDATA[Payers and Providers Map the Path to Community CAR T Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/weekend-catch-up-sleep-linked-to-lower-odds-of-overactive-bladder</loc><lastmod>2026-09-30T18:36:03.440Z</lastmod><news:news><news:publication_date>2026-09-30T18:36:03.440Z</news:publication_date>
        <news:title><![CDATA[Weekend Catch-Up Sleep Linked to Lower Odds of Overactive Bladder]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cms-projects-16-5-drop-in-2027-medicare-advantage-premiums</loc><lastmod>2026-09-30T18:00:00Z</lastmod><news:news><news:publication_date>2026-09-30T18:00:00Z</news:publication_date>
        <news:title><![CDATA[CMS Projects 16.5% Drop in 2027 Medicare Advantage Premiums]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/patients-with-cancer-are-building-ai-tools-to-provide-second-opinions-and-treatment-options</loc><lastmod>2026-09-30T17:51:00Z</lastmod><news:news><news:publication_date>2026-09-30T17:51:00Z</news:publication_date>
        <news:title><![CDATA[Patients With Cancer Are Building AI Tools to Provide Second Opinions and Treatment Options]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/oncologists-grapple-with-sequencing-access-as-treatments-multiply</loc><lastmod>2026-09-30T15:37:49.228Z</lastmod><news:news><news:publication_date>2026-09-30T15:37:49.228Z</news:publication_date>
        <news:title><![CDATA[Oncologists Grapple With Sequencing, Access as Treatments Multiply]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/oveporexton-improves-wakefulness-and-cataplexy-in-narcolepsy-type-1</loc><lastmod>2026-09-30T15:00:00Z</lastmod><news:news><news:publication_date>2026-09-30T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Oveporexton Improves Wakefulness and Cataplexy in Narcolepsy Type 1]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/inspire2026-ai-patient-access-in-specialty-pharmacy-practices-today</loc><lastmod>2026-09-30T14:50:00Z</lastmod><news:news><news:publication_date>2026-09-30T14:50:00Z</news:publication_date>
        <news:title><![CDATA[inSPire2026: AI, Patient Access in Specialty Pharmacy Practices Today]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/retatrutide-yields-up-to-20-8-weight-loss-in-obesity-with-t2d</loc><lastmod>2026-09-30T14:02:36.324Z</lastmod><news:news><news:publication_date>2026-09-30T14:02:36.324Z</news:publication_date>
        <news:title><![CDATA[Retatrutide Yields Up to 20.8% Weight Loss in Obesity With T2D]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/limited-stage-sclc-chemoradiotherapy-standards-and-scheduling-decisions</loc><lastmod>2026-09-30T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-30T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Limited-Stage SCLC: Chemoradiotherapy Standards and Scheduling Decisions]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/diagnosing-aatd-levels-genotype-and-the-diagnostic-gap</loc><lastmod>2026-09-30T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-30T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Diagnosing AATD: Levels, Genotype, and the Diagnostic Gap]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/choosing-a-first-line-chemotherapy-backbone-and-maintenance-strategy-in-mcrc</loc><lastmod>2026-09-29T12:05:00.000Z</lastmod><news:news><news:publication_date>2026-09-30T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Choosing a First-Line Chemotherapy Backbone and Maintenance Strategy in mCRC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/evaluating-suspected-lems-differential-diagnosis-and-palliative-care-s-role</loc><lastmod>2026-09-30T12:03:00Z</lastmod><news:news><news:publication_date>2026-09-30T12:03:00Z</news:publication_date>
        <news:title><![CDATA[Evaluating Suspected LEMS: Differential Diagnosis and Palliative Care's Role]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/lems-in-small-cell-lung-cancer-definition-pathophysiology-and-prognosis</loc><lastmod>2026-09-30T12:01:00Z</lastmod><news:news><news:publication_date>2026-09-30T12:01:00Z</news:publication_date>
        <news:title><![CDATA[LEMS in Small Cell Lung Cancer: Definition, Pathophysiology, and Prognosis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/aatd-genetics-z-allele-codominance-and-predisposition-risk</loc><lastmod>2026-09-30T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[AATD Genetics: Z Allele, Codominance, and Predisposition Risk]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/how-network-meta-analyses-compare-adjunctive-antipsychotics-in-mdd</loc><lastmod>2026-09-30T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[How Network Meta-Analyses Compare Adjunctive Antipsychotics in MDD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/sclc-staging-and-screening-limited--vs-extensive-stage-disease</loc><lastmod>2026-09-30T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[SCLC Staging and Screening: Limited- vs Extensive-Stage Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/biomarker-testing-and-molecular-subtyping-in-first-line-mcrc</loc><lastmod>2026-09-29T12:00:00.000Z</lastmod><news:news><news:publication_date>2026-09-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Biomarker Testing and Molecular Subtyping in First-Line mCRC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/vibegron-outranks-mirabegron-tolterodine-on-several-oab-measures</loc><lastmod>2026-09-29T21:30:00Z</lastmod><news:news><news:publication_date>2026-09-29T21:30:00Z</news:publication_date>
        <news:title><![CDATA[Vibegron Outranks Mirabegron, Tolterodine on Several OAB Measures]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/drug-price-drives-value-of-mash-therapies-more-than-efficacy</loc><lastmod>2026-09-29T20:53:49.590Z</lastmod><news:news><news:publication_date>2026-09-29T20:53:49.590Z</news:publication_date>
        <news:title><![CDATA[Drug Price Drives Value of MASH Therapies More Than Efficacy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/advancing-care-in-cll-richter-transformation-adam-s-kittai-md</loc><lastmod>2026-09-29T20:41:19.302Z</lastmod><news:news><news:publication_date>2026-09-29T20:41:19.302Z</news:publication_date>
        <news:title><![CDATA[Advancing Care in CLL Richter Transformation: Adam S. Kittai, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ira-340b-medicaid-the-policy-pressures-on-community-oncology</loc><lastmod>2026-09-29T20:15:24.909Z</lastmod><news:news><news:publication_date>2026-09-29T20:15:24.909Z</news:publication_date>
        <news:title><![CDATA[IRA, 340B, Medicaid: The Policy Pressures on Community Oncology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/symptom-tracking-may-aid-endometriosis-care-but-evidence-is-limited</loc><lastmod>2026-09-29T20:13:58.931Z</lastmod><news:news><news:publication_date>2026-09-29T20:13:58.931Z</news:publication_date>
        <news:title><![CDATA[Symptom Tracking May Aid Endometriosis Care, but Evidence Is Limited]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/why-cancer-drug-access-takes-time-scott-a-soefje-pharmd-mba</loc><lastmod>2026-09-29T20:07:19.956Z</lastmod><news:news><news:publication_date>2026-09-29T20:07:19.956Z</news:publication_date>
        <news:title><![CDATA[Why Cancer Drug Access Takes Time: Scott A. Soefje, PharmD, MBA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ma-switching-surges-among-dually-eligible-adults-grace-mackleby-phd</loc><lastmod>2026-09-29T20:00:00Z</lastmod><news:news><news:publication_date>2026-09-29T20:00:00Z</news:publication_date>
        <news:title><![CDATA[MA Switching Surges Among Dually Eligible Adults: Grace Mackleby, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/-pay-for-the-care-not-only-the-vial-the-hidden-costs-of-cancer-care</loc><lastmod>2026-09-29T19:59:15.790Z</lastmod><news:news><news:publication_date>2026-09-29T19:59:15.790Z</news:publication_date>
        <news:title><![CDATA["Pay for the Care, Not Only the Vial": The Hidden Costs of Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ai-innovation-in-community-oncology-is-not-all-hype</loc><lastmod>2026-09-29T19:56:05.855Z</lastmod><news:news><news:publication_date>2026-09-29T19:56:05.855Z</news:publication_date>
        <news:title><![CDATA[AI Innovation in Community Oncology Is Not All Hype]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/boston-experts-weigh-access-sequencing-and-testing-across-4-cancers</loc><lastmod>2026-09-29T19:40:36.119Z</lastmod><news:news><news:publication_date>2026-09-29T19:40:36.119Z</news:publication_date>
        <news:title><![CDATA[Boston Experts Weigh Access, Sequencing, and Testing Across 4 Cancers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/caregiver-gaps-limit-access-to-new-therapies-thomas-leblanc-md-ma</loc><lastmod>2026-09-29T19:30:59.428Z</lastmod><news:news><news:publication_date>2026-09-29T19:30:59.428Z</news:publication_date>
        <news:title><![CDATA[Caregiver Gaps Limit Access to New Therapies: Thomas LeBlanc, MD, MA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/patients-with-hepatitis-remain-undetectable-at-least-96-weeks-after-stopping-bulevirtide</loc><lastmod>2026-09-29T19:04:12.936Z</lastmod><news:news><news:publication_date>2026-09-29T19:04:12.936Z</news:publication_date>
        <news:title><![CDATA[Patients Remain Undetectable 96 Weeks After Stopping Bulevirtide]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/oncology-experts-call-for-less-toxic-care-smarter-access</loc><lastmod>2026-09-29T18:44:04.449Z</lastmod><news:news><news:publication_date>2026-09-29T18:44:04.449Z</news:publication_date>
        <news:title><![CDATA[Oncology Experts Call for Less Toxic Care, Smarter Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/combined-immunonutrients-may-cut-wound-infection-in-colorectal-surgery</loc><lastmod>2026-09-29T17:00:00Z</lastmod><news:news><news:publication_date>2026-09-29T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Combined Immunonutrients May Cut Wound Infection in Colorectal Surgery]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/coa-elevates-3-staff-leaders-hires-new-director-of-communications</loc><lastmod>2026-09-29T16:22:00Z</lastmod><news:news><news:publication_date>2026-09-29T16:22:00Z</news:publication_date>
        <news:title><![CDATA[COA Elevates 3 Staff Leaders, Hires New Director of Communications]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tennessee-oncology-is-first-to-earn-fact-accreditation-under-new-standards</loc><lastmod>2026-09-29T15:45:00Z</lastmod><news:news><news:publication_date>2026-09-29T15:45:00Z</news:publication_date>
        <news:title><![CDATA[Tennessee Oncology Is First to Earn FACT Accreditation Under New Standards]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tennessee-oncology-taps-kate-baker-md-mmhc-for-supportive-care-services-role</loc><lastmod>2026-09-29T15:34:00Z</lastmod><news:news><news:publication_date>2026-09-29T15:34:00Z</news:publication_date>
        <news:title><![CDATA[Tennessee Oncology Taps Kate Baker, MD, MMHC, for Supportive Care Services Role]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/inflammation-tied-to-overactive-bladder-odds-partly-via-adiposity</loc><lastmod>2026-09-29T15:16:52.669Z</lastmod><news:news><news:publication_date>2026-09-29T15:16:52.669Z</news:publication_date>
        <news:title><![CDATA[Inflammation Tied to Overactive Bladder Odds, Partly via Adiposity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/combo-glp-1-ra-sglt2-therapy-linked-to-lower-kidney-cv-risks</loc><lastmod>2026-09-29T14:30:00Z</lastmod><news:news><news:publication_date>2026-09-29T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Combo GLP-1 RA, SGLT2 Therapy Linked to Lower Kidney, CV Risks]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cd70-emerges-as-target-to-overcome-treatment-resistance-in-mcl</loc><lastmod>2026-09-29T13:29:00Z</lastmod><news:news><news:publication_date>2026-09-29T13:29:00Z</news:publication_date>
        <news:title><![CDATA[CD70 Emerges as Target to Overcome Treatment Resistance in MCL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/pbm-satisfaction-stalls-as-net-promoter-score-turns-negative</loc><lastmod>2026-09-29T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-29T13:00:00Z</news:publication_date>
        <news:title><![CDATA[PBM Satisfaction Stalls as Net Promoter Score Turns Negative]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/sglt2-inhibitors-vs-glp-1-receptor-agonists-in-heart-failure</loc><lastmod>2026-09-29T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-29T12:05:00Z</news:publication_date>
        <news:title><![CDATA[SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Heart Failure]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/switching-sglt2-inhibitors-generic-transitions-and-continuity-of-care</loc><lastmod>2026-09-29T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-29T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Switching SGLT2 Inhibitors: Generic Transitions and Continuity of Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/access-and-innovation-in-north-carolina-s-research-triangle</loc><lastmod>2026-09-28T23:30:59.784Z</lastmod><news:news><news:publication_date>2026-09-28T23:30:59.784Z</news:publication_date>
        <news:title><![CDATA[Access and Innovation in North Carolina’s Research Triangle]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/medicare-cap-eases-patient-costs-as-negotiation-squeezes-practices</loc><lastmod>2026-09-28T21:30:14.812Z</lastmod><news:news><news:publication_date>2026-09-28T21:30:14.812Z</news:publication_date>
        <news:title><![CDATA[Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/an-odyssey-of-symptoms-setbacks-treatments-and-a-cure-with-car-t-cell-therapy</loc><lastmod>2026-09-28T21:25:00Z</lastmod><news:news><news:publication_date>2026-09-28T21:25:00Z</news:publication_date>
        <news:title><![CDATA[An Odyssey of Symptoms, Setbacks, Treatments, and a Cure With CAR T-Cell Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/trusted-messengers-key-to-hiv-outreach-christina-madison-pharmd</loc><lastmod>2026-09-28T21:10:15.760Z</lastmod><news:news><news:publication_date>2026-09-28T21:10:15.760Z</news:publication_date>
        <news:title><![CDATA[Trusted Messengers Key to HIV Outreach: Christina Madison, PharmD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/pharmacies-can-close-hiv-awareness-gap-in-youth-kevin-astle-pharmd</loc><lastmod>2026-09-28T20:47:37.068Z</lastmod><news:news><news:publication_date>2026-09-28T20:47:37.068Z</news:publication_date>
        <news:title><![CDATA[Pharmacies Can Close HIV Awareness Gap in Youth: Kevin Astle, PharmD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/education-is-key-as-precision-oncology-advances-william-k-oh-md</loc><lastmod>2026-09-28T20:45:29.818Z</lastmod><news:news><news:publication_date>2026-09-28T20:45:29.818Z</news:publication_date>
        <news:title><![CDATA[Education Is Key as Precision Oncology Advances: William K. Oh, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/overcoming-barriers-to-precision-care-and-patient-access</loc><lastmod>2026-09-28T20:14:23.863Z</lastmod><news:news><news:publication_date>2026-09-28T20:14:23.863Z</news:publication_date>
        <news:title><![CDATA[Overcoming Barriers to Precision Care and Patient Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-the-cell-therapy-reimbursement-gap-christine-pfaff-rph-mba</loc><lastmod>2026-09-28T19:30:00Z</lastmod><news:news><news:publication_date>2026-09-28T19:30:00Z</news:publication_date>
        <news:title><![CDATA[Closing the Cell Therapy Reimbursement Gap: Christine Pfaff, RPh, MBA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/biomarker-driven-care-is-racing-ahead-of-the-systems-built-to-support-it</loc><lastmod>2026-09-28T17:46:49.574Z</lastmod><news:news><news:publication_date>2026-09-28T17:46:49.574Z</news:publication_date>
        <news:title><![CDATA[Biomarker-Driven Care Is Racing Ahead of the Systems Built to Support It]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/home-phototherapy-matches-office-care-for-psoriasis-but-stays-underused</loc><lastmod>2026-09-28T17:00:00Z</lastmod><news:news><news:publication_date>2026-09-28T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Home Phototherapy Matches Office Care for Psoriasis but Stays Underused]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/employers-need-a-voice-in-shaping-cancer-care-rosa-novo</loc><lastmod>2026-09-28T16:00:00Z</lastmod><news:news><news:publication_date>2026-09-28T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Employers Need a Voice in Shaping Cancer Care: Rosa Novo]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tumor-location-shapes-surgical-path-in-synovial-sarcoma</loc><lastmod>2026-09-28T14:51:20.219Z</lastmod><news:news><news:publication_date>2026-09-28T14:51:20.219Z</news:publication_date>
        <news:title><![CDATA[Tumor Location Shapes Surgical Path in Synovial Sarcoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ai-poised-to-reshape-drug-development-david-spigel-md</loc><lastmod>2026-09-28T13:37:59.686Z</lastmod><news:news><news:publication_date>2026-09-28T13:37:59.686Z</news:publication_date>
        <news:title><![CDATA[AI Poised to Reshape Drug Development: David Spigel, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tavapadon-for-parkinson-disease-approved-by-fda</loc><lastmod>2026-09-28T13:35:26.726Z</lastmod><news:news><news:publication_date>2026-09-28T13:35:26.726Z</news:publication_date>
        <news:title><![CDATA[Tavapadon for Parkinson Disease Approved by FDA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/baricitinib-approved-for-severe-alopecia-areata-in-adolescents</loc><lastmod>2026-09-28T13:15:35.037Z</lastmod><news:news><news:publication_date>2026-09-28T13:15:35.037Z</news:publication_date>
        <news:title><![CDATA[Baricitinib Approved for Severe Alopecia Areata in Adolescents]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/dme-drug-remigromig-hits-primary-end-point-in-phase-3-trial</loc><lastmod>2026-09-28T13:04:25.479Z</lastmod><news:news><news:publication_date>2026-09-28T13:04:25.479Z</news:publication_date>
        <news:title><![CDATA[DME Drug Remigromig Hits Primary End Point in Phase 2b/3 Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/designing-a-better-managed-care-benefit-for-alzheimer-s-disease</loc><lastmod>2026-09-28T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-28T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Designing a Better Managed Care Benefit for Alzheimer's Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/achieving-equitable-community-car-t-cell-access</loc><lastmod>2026-09-28T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-28T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Achieving Equitable Community CAR T-Cell Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/what-payers-need-to-see-from-new-complicated-uti-therapies</loc><lastmod>2026-09-28T12:03:00Z</lastmod><news:news><news:publication_date>2026-09-28T12:03:00Z</news:publication_date>
        <news:title><![CDATA[What Payers Need to See From New Complicated UTI Therapies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/defining-the-clinical-and-economic-burden-of-complicated-uti</loc><lastmod>2026-09-28T12:01:00Z</lastmod><news:news><news:publication_date>2026-09-28T12:01:00Z</news:publication_date>
        <news:title><![CDATA[Defining the Clinical and Economic Burden of Complicated UTI]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-path-forward-for-community-car-t-cell-therapy</loc><lastmod>2026-09-28T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-28T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Path Forward for Community CAR T-Cell Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/blood-based-biomarkers-reshaping-the-alzheimer-s-disease-diagnostic-toolkit</loc><lastmod>2026-09-28T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-28T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Blood-Based Biomarkers: Reshaping the Alzheimer's Disease Diagnostic Toolkit]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-awareness-gaps-in-employer-cancer-benefits-amanda-green-mph</loc><lastmod>2026-09-27T14:00:00Z</lastmod><news:news><news:publication_date>2026-09-27T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Closing Awareness Gaps in Employer Cancer Benefits: Amanda Green, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tampa-experts-weigh-the-economics-of-bringing-bispecifics-to-community-care</loc><lastmod>2026-09-27T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-27T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Tampa Experts Weigh the Economics of Bringing Bispecifics to Community Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/relevant-contact-allergy-found-in-41-of-hand-eczema-referred-for-testing</loc><lastmod>2026-09-27T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-27T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Relevant Contact Allergy Found in 41% of Hand Eczema Referred for Testing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/nccn-journal-publishes-guidelines-update-in-mantle-cell-lymphoma</loc><lastmod>2026-09-26T19:02:00Z</lastmod><news:news><news:publication_date>2026-09-26T19:02:00Z</news:publication_date>
        <news:title><![CDATA[NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ai-and-the-future-of-community-oncology-debra-patt-md-phd-mba-mph</loc><lastmod>2026-09-26T17:00:00Z</lastmod><news:news><news:publication_date>2026-09-26T17:00:00Z</news:publication_date>
        <news:title><![CDATA[AI and the Future of Community Oncology: Debra Patt, MD, PhD, MBA, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/why-cancer-diagnoses-rise-as-deaths-fall-david-a-siegel-md-mph</loc><lastmod>2026-09-26T16:15:17.533Z</lastmod><news:news><news:publication_date>2026-09-26T16:15:17.533Z</news:publication_date>
        <news:title><![CDATA[Why Cancer Diagnoses Rise as Deaths Fall: David A. Siegel, MD, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/community-care-consultations-for-veterans-with-diabetic-foot-ulcers</loc><lastmod>2026-09-26T16:00:00Z</lastmod><news:news><news:publication_date>2026-09-26T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Community Care Consultations for Veterans with Diabetic Foot Ulcers ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/reimagining-value-based-contracts-for-high-cost-therapies</loc><lastmod>2026-09-26T14:44:36.286Z</lastmod><news:news><news:publication_date>2026-09-26T14:44:36.286Z</news:publication_date>
        <news:title><![CDATA[Reimagining Value-Based Contracts for High-Cost Therapies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/advanced-primary-care-aids-cancer-prevention-karen-van-caulil-phd</loc><lastmod>2026-09-26T14:00:00Z</lastmod><news:news><news:publication_date>2026-09-26T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Advanced Primary Care Aids Cancer Prevention: Karen van Caulil, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/health-system-pharmacies-keep-patients-on-glp-1-therapy</loc><lastmod>2026-09-25T21:19:59.172Z</lastmod><news:news><news:publication_date>2026-09-25T21:19:59.172Z</news:publication_date>
        <news:title><![CDATA[Health System Pharmacies Keep Patients on GLP-1 Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/low-glp-1-discontinuation-in-specialty-pharmacy-sophy-levine-pharmd</loc><lastmod>2026-09-25T21:00:00Z</lastmod><news:news><news:publication_date>2026-09-25T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Low GLP-1 Discontinuation in Specialty Pharmacy: Sophy Levine, PharmD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/why-4-in-5-eligible-adults-miss-lung-cancer-screening</loc><lastmod>2026-09-25T20:26:27.319Z</lastmod><news:news><news:publication_date>2026-09-25T20:26:27.319Z</news:publication_date>
        <news:title><![CDATA[Why 4 in 5 Eligible Adults Miss Lung Cancer Screening]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/5-notable-fda-approvals-from-the-first-half-of-september</loc><lastmod>2026-09-25T20:15:31.999Z</lastmod><news:news><news:publication_date>2026-09-25T20:15:31.999Z</news:publication_date>
        <news:title><![CDATA[5 Notable FDA Approvals From the First Half of September]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/faq-what-the-measles-outbreak-means-for-payers-and-health-systems</loc><lastmod>2026-09-25T19:56:37.956Z</lastmod><news:news><news:publication_date>2026-09-25T19:56:37.956Z</news:publication_date>
        <news:title><![CDATA[FAQ: What the Measles Outbreak Means for Payers and Health Systems]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/peptide-regulation-debate-intensifies-after-fda-advisory-panel-s-controversial-vote</loc><lastmod>2026-09-25T19:45:53.081Z</lastmod><news:news><news:publication_date>2026-09-25T19:45:53.081Z</news:publication_date>
        <news:title><![CDATA[ Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/health-equity-access-weekly-roundup-september-25-2026</loc><lastmod>2026-09-25T19:36:12.843Z</lastmod><news:news><news:publication_date>2026-09-25T19:36:12.843Z</news:publication_date>
        <news:title><![CDATA[Health Equity & Access Weekly Roundup: September 25, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/community-oncologists-ready-to-innovate-but-barriers-remain</loc><lastmod>2026-09-25T19:31:28.185Z</lastmod><news:news><news:publication_date>2026-09-25T19:31:28.185Z</news:publication_date>
        <news:title><![CDATA[Community Oncologists Ready to Innovate, but Barriers Remain]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-tissue-systems-pathology-test-predicts-risk-of-progression-to-high-grade-dysplasia-or-esophageal-adenocarcinoma-for-patients-with-non-dysplastic-barrett-s-esophagus</loc><lastmod>2026-09-25T18:56:48.109Z</lastmod><news:news><news:publication_date>2026-09-25T18:56:48.109Z</news:publication_date>
        <news:title><![CDATA[The Tissue Systems Pathology Test Predicts Risk of Progression to High-Grade Dysplasia or Esophageal Adenocarcinoma for Patients With Non-Dysplastic Barrett's Esophagus]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/melatonin-use-linked-to-small-rem-sleep-reduction-in-children</loc><lastmod>2026-09-25T18:34:45.523Z</lastmod><news:news><news:publication_date>2026-09-25T18:34:45.523Z</news:publication_date>
        <news:title><![CDATA[Melatonin Use Linked to Small REM Sleep Reduction in Children]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/barriers-to-community-trial-enrollment-lucio-n-gordan-md</loc><lastmod>2026-09-25T18:15:55.146Z</lastmod><news:news><news:publication_date>2026-09-25T18:15:55.146Z</news:publication_date>
        <news:title><![CDATA[Barriers to Community Trial Enrollment: Lucio N. Gordan, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/clinical-claims-data-guide-care-gold-carding-david-johnson-md-mph</loc><lastmod>2026-09-25T17:59:57.390Z</lastmod><news:news><news:publication_date>2026-09-25T17:59:57.390Z</news:publication_date>
        <news:title><![CDATA[Clinical, Claims Data Guide Care, Gold Carding: David Johnson, MD, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/price-not-science-drives-obesity-glp-1-access-holly-lofton-md</loc><lastmod>2026-09-25T17:30:42.353Z</lastmod><news:news><news:publication_date>2026-09-25T17:30:42.353Z</news:publication_date>
        <news:title><![CDATA[Price, Not Science, Drives Obesity GLP-1 Access: Holly Lofton, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/reimagining-value-based-deals-through-risk-pooling-models</loc><lastmod>2026-09-25T17:11:14.299Z</lastmod><news:news><news:publication_date>2026-09-25T17:11:14.299Z</news:publication_date>
        <news:title><![CDATA[ Reimagining Value-Based Deals Through Risk-Pooling Models]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-glp-1-access-gaps-in-obesity-care-adaolisa-anaka-pharmd-bcacp-aahivp</loc><lastmod>2026-09-25T17:00:00Z</lastmod><news:news><news:publication_date>2026-09-25T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Closing GLP-1 Access Gaps in Obesity Care: Adaolisa Anaka, PharmD, BCACP, AAHIVP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/priority-health-brings-php-tpa-services-to-michigan-employers</loc><lastmod>2026-09-25T16:38:47.757Z</lastmod><news:news><news:publication_date>2026-09-25T16:38:47.757Z</news:publication_date>
        <news:title><![CDATA[Priority Health Brings PHP TPA Services to Michigan Employers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/nccn-concordance-doesn-t-guarantee-cancer-drug-coverage</loc><lastmod>2026-09-25T16:15:00Z</lastmod><news:news><news:publication_date>2026-09-25T16:15:00Z</news:publication_date>
        <news:title><![CDATA[NCCN Concordance Doesn't Guarantee Cancer Drug Coverage]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/liquid-biopsy-reshapes-precision-medicine-lori-brisbin-ms-mls</loc><lastmod>2026-09-25T16:00:27.094Z</lastmod><news:news><news:publication_date>2026-09-25T16:00:27.094Z</news:publication_date>
        <news:title><![CDATA[Liquid Biopsy Reshapes Precision Medicine: Lori Brisbin, MS, MLS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/opposing-sides-of-340b-debate-converge-on-data-clearinghouse-patient-definition</loc><lastmod>2026-09-25T15:54:18.182Z</lastmod><news:news><news:publication_date>2026-09-25T15:54:18.182Z</news:publication_date>
        <news:title><![CDATA[Opposing Sides of 340B Debate Converge on Data Clearinghouse, Patient Definition]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-sdoh-gaps-in-specialty-pharmacy-irfana-lakada-pharmd-csp</loc><lastmod>2026-09-25T15:30:00Z</lastmod><news:news><news:publication_date>2026-09-25T15:30:00Z</news:publication_date>
        <news:title><![CDATA[Closing SDOH Gaps in Specialty Pharmacy: Irfana Lakada PharmD, CSP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-belzutifan-lenvatinib-combo-for-advanced-kidney-cancer</loc><lastmod>2026-09-25T14:29:35.015Z</lastmod><news:news><news:publication_date>2026-09-25T14:29:35.015Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Belzutifan-Lenvatinib Combo for Advanced Kidney Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/real-world-data-back-dupilumab-s-long-term-use-in-pediatric-ad</loc><lastmod>2026-09-25T14:20:52.398Z</lastmod><news:news><news:publication_date>2026-09-25T14:20:52.398Z</news:publication_date>
        <news:title><![CDATA[Real-World Data Back Dupilumab's Long-Term Use in Pediatric AD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/overactive-bladder-predictors-in-women-extend-beyond-age-bmi</loc><lastmod>2026-09-25T13:47:36.021Z</lastmod><news:news><news:publication_date>2026-09-25T13:47:36.021Z</news:publication_date>
        <news:title><![CDATA[Overactive Bladder Predictors in Women Extend Beyond Age, BMI]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/philadelphia-experts-share-how-bispecific-delivery-in-myeloma-varies-by-site</loc><lastmod>2026-09-25T13:29:00Z</lastmod><news:news><news:publication_date>2026-09-25T13:29:00Z</news:publication_date>
        <news:title><![CDATA[Philadelphia Experts Share How Bispecific Delivery in Myeloma Varies by Site]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>